期刊文献+

肿瘤坏死因子α及β基因多态性与多发性硬化关系的研究 被引量:3

Correlation between tumor necrosis factorαandβgene polymorphisms and multiple sclerosis
原文传递
导出
摘要 目的探讨肿瘤坏死因子α(TNFα)及β(TNFβ)基因多态性与多发性硬化(MS)的相关性。方法采用序列特异性引物和聚合酶链式反应(PCR)、限制性内切酶酶切技术对60例MS患者(MS组)和110例健康者(对照组)的TNFα及β基因多态性进行分析。结果MS组TNFα-308等位基因分布频率与对照组比较有显著性差异(P=0.04),且MS组等位基因A含量(3.3%)与对照组(11.8%)比较也有显著性差异(P=0.008);MS组TNFβ+252等位基因分布频率与对照组比较有显著性差异(P=0.014),且MS组等位基因A含量(69.2%)与对照组(55.5%)比较也有显著性差异(P=0.014)。结论TNFα-308 A等位基因的多态性与MS的发病有一定负相关,TNFβ+252 A等位基因频率及TNFβ+252 A/A基因分布频率与MS的发病有一定正相关。 Objective To investigate the correlation between tumor necrosis factor α (TNFα) and β (TNFβ) gene polymorphisms and multiple sclerosis (MS). Methods TNFα and TNFβ gene polymorphisms were analyzed in 60 MS patients (MS group) and 110 healthy people (control group) with sequence specific primer and polymerase chain reaction (PCR), and restriction endonuclease technology. Results There was a significant difference in TNFα-308 allelic gene frequency between MS group and control group(P=0.04), and TNFα allelic gene A content in MS group(3.3%) was also significantly different from that in control group (11.8%, P=-0.008). There was a significant difference in TNFβ+252 allelic gene frequency between the 2 groups(P=0.014), and TNFβ allelic gene A content in MS group(69.2%) was also significantly different as compared with control group (55.5%, P=0.014). Conclusion There was a negative correlation between MS group and control group in TNFα-308 A allelic gene frequency, but a positive correlation in TNF-β+252 A allelic gene frequency and TNF-β+252 A/A gene frequency.
出处 《中华神经医学杂志》 CAS CSCD 2006年第6期572-575,共4页 Chinese Journal of Neuromedicine
关键词 肿瘤坏死因子Α 肿瘤坏死因子Β 多发性硬化 聚合酶链式反应 限制性内切酶酶切 基因多态性 Tumor necrosis factor α Tumor necrosis factor β Multiplesclerosis Polymerase chain reaction Restriction endonuclease technology Gene polymorphism
  • 相关文献

参考文献10

  • 1马建军,徐予明,徐军,连亚军,西村公孝,齐田孝彦.亚洲型和西方型多发性硬化髓磷脂少突胶质细胞糖蛋白微卫星等位基因多态性的比较[J].郑州大学学报(医学版),2003,38(4):506-508. 被引量:7
  • 2Poser CM, Paty DN, Scheinberg L, et al. New diagnosis criteria for multiple sclerosis: guideline for research protocols[J]. Ann Neurol,1998, 13(3): 227-231.
  • 3Drulovic J, Popadic D, Mesaros S, et al. Decreased frequency of the tumor necrosis factor alpha-308 allele in Serbian patients with multiple sclerosis[J]. Eur Neurol, 2003, 50(1): 25-29.
  • 4Um JY, An NH, Kim HM. TNF-alpha and TNF-beta gene polymorphism in cerebral infarction[J]. Mol Neurosci, 2003, 21 (2):167-171.
  • 5Elneihoum AM, Falke P, Hedblad B, et al. Leukocyte activation in atherosclerosis:correlation with risk factors[J]. Atherosclerosis, 1997,131(1): 79.
  • 6Fernandez-Arquero M, Arroyo R, Rubio A, et al. Primary association of a TNF gene polymorphism with susceptibility to multiple sclerosis[J]. Neurology, 1999, 53(6): 1361-1363.
  • 7Braun N, Michel U, Ernst BP, et al. Gene polymorphism at position-308 of the tumor necrosis factor-alpha (TNF-alpha) in multiple sclerosis and it's influence on the regulation of TNF-alpha production[J].Neurosci Lett, 1996, 215(2): 75-78.
  • 8McDevitt H, Munson S, Ettinger R, et al. Multiple roles for tumor necrosis factor-alpha and lymphotoxin alpha/beta in immunity and autoimmunity[J]. Arthritis Res, 2002, 4(suppl 3): 141-152.
  • 9Koch W, Kastrati A, Bottiger C, et al. Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction[J]. Atherosclerosis, 2001, 159(1):137-144.
  • 10UM JY, Kim HM. Tumor necrosis factor alpha gene polymorphism is associated with cerebral infarction[J]. Molecular Brain Research,2004, 122(1): 99-102.

二级参考文献12

  • 1王洪林.多发性硬化[A].侯熙德主编.神经病学:第3版[C].北京:人民卫生出版社,1996.156.
  • 2Kira J, Kanai T, Nishimura Y,et al. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorder. Ann Neurol, 1996,40(4) :569.
  • 3Ma JJ, Nishimura M, Mine H, et al. HLA-DRB1 and tumor necrosis factor gene polymorphisms in Japanese patients with multiple sclerosis. J Neuroimmunol, 1998,92(1-2) : 109.
  • 4Scolding N J, Firth S, Linington C, et al. Myelin-oligodendrocyte glycoprotein(MOG) is a surface marker of oligodendrocyte maturation. J Neuroimmunol, 1989,22(3) : 169.
  • 5Brok HP, Uccelli A, Kerlero De Rosbo N, et al. Myelin/oligodendrocyte glycoprotein-induced autoimmuno encephalomyelitis in common marmosets: the encephalitogenic T cell epitope pMOG24-36 is presented by a monomorphic MHC class Ⅱ molecule. J Immunol, 2000,165(2) :1093.
  • 6Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol,1983,13(3) :227.
  • 7Kurtzke JF. Rating neurologic impairment in multiple sclerosis :an expanded disability status scale (EDSS). Neurology,1983,33(11) :1444.
  • 8Roth MP, Malfroy L, Offer C, et al. The human myelin oligodendrocyte glycoprotein (MOG) gene : complete nucleotide sequence and structural characterization. Genomics, 1995,28(2) :241.
  • 9Yamasaki K , Horiuchi I, Minohara M, et al. HLA-DPB10501-associated opticospinal multiple sclerosis :clinical, neuroimaging and immunogenetic studies. Brain, 1999, 122(Pt9) :1689.
  • 10Pham-Dinh D, Mattei MG, Nussbaum JL, et al. Myelin oligodendrocyte glycoprotein is a member of a subjcet of the immunoglobulin superfamily encoded within the major histocompatibility complex. Proc Natl Acad Sci USA, 1993,90(17) :7990.

共引文献6

同被引文献62

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部